| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.5 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.5 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |